Thermo Fisher Scientific Acquires BRAHMS
Thermo Fisher Scientific Inc has signed a definitive agreement to acquire B.R.A.H.M.S. AG for 330 million (approximately $470 million USD).
Read MoreSearch Results for: point-of-care testing
Tox Testing for Drugs of Abuse and Therapeutic Monitoring
Rapid immunoassays lead the pack but LC/MS finds increasing application.
Read More
Point-of-Care Products: Highlights, Trends and Emerging Technologies
Point-of-care testing aims to improve health care with quick turnaround times.
Read MoreRoche Cardiac 200 Offers Rapid Cardiac Diagnostics for PoC
Roche Diagnostics announced today the introduction of the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.
Read MoreFenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
Fenwal Inc announced that it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, sell and distribute Verax’s unique PanGenera Detection (PGD) technology, a rapid diagnostic test used to detect bacterial contaminants in donated blood platelets.
Read More